We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 234 results
  1. Idarubicin combats abiraterone and enzalutamide resistance in prostate cells via targeting XPA protein

    Although second-generation therapies like abiraterone (ABI) and enzalutamide (ENZ) benefit patients with castration-resistant prostate cancer (CRPC),...

    Ying Zhang, Wei Wei, ... Changlin Li in Cell Death & Disease
    Article Open access 12 December 2022
  2. Low-Dose Triptolide Enhanced Activity of Idarubicin Against Acute Myeloid Leukemia Stem-like Cells Via Inhibiting DNA Damage Repair Response

    Leukemia stem cells (LSCs) are considered to be the root of relapse for acute myeloid leukemia (AML). Conventional chemotherapeutic drugs fail to...

    Pengcheng Shi, Jie Zha, ... Bing Xu in Stem Cell Reviews and Reports
    Article 19 October 2020
  3. Anthracycline-induced cytotoxicity in the GL261 glioma model system

    Glioblastoma (GBM) is a lethal astrocyte-derived tumor that is currently treated with a multi-modal approach of surgical resection, radiotherapy, and...

    Amber M. Tavener, Megan C. Phelps, Richard L. Daniels in Molecular Biology Reports
    Article Open access 02 January 2021
  4. 1, 4-naphthoquinone efficiently facilitates the disintegration of pre-existing biofilm of Staphylococcus aureus through eDNA intercalation

    1, 4-naphthoquinone, a plant-based quinone derivative, has gained much attention for its effectiveness against several biofilm-linked diseases. The...

    Payel Paul, Sarita Sarkar, ... Prosun Tribedi in Folia Microbiologica
    Article 05 May 2023
  5. An overview of arsenic trioxide-involved combined treatment algorithms for leukemia: basic concepts and clinical implications

    Arsenic trioxide is a first-line treatment drug for acute promyelocytic leukemia, which is also effective for other kinds of leukemia. Its side...

    Yanan Jiang, **uyun Shen, ... Yunlong Bai in Cell Death Discovery
    Article Open access 27 July 2023
  6. Early changes in gene expression profiles in AML patients during induction chemotherapy

    Background

    Elucidation of the genetic mechanisms underlying treatment response to standard induction chemotherapy in AML patients is warranted, in...

    Ingrid Jakobsen, Max Sundkvist, ... Kourosh Lotfi in BMC Genomics
    Article Open access 14 November 2022
  7. MSI2 promotes translation of multiple IRES-containing oncogenes and virus to induce self-renewal of tumor initiating stem-like cells

    Abstract

    RNA-binding protein Musashi 2 (MSI2) is elevated in several cancers and is linked to poor prognosis. Here, we tested if MSI2 promotes MYC and...

    Da-Wei Yeh, Xuyao Zhao, ... Keigo Machida in Cell Death Discovery
    Article Open access 28 April 2023
  8. Clinical Studies and Epi-Drugs in Various Cancer Types

    Cancer is characterized by modifications in the epigenetic mechanisms and chromatin functions. Alterations in gene expression, as well as the...
    Taha Bahsi, Ezgi Cevik, ... Haktan Bagis Erdem in Cancer Epigenetics
    Chapter 2023
  9. Establishment and characterization of NCC-MRT1-C1: a novel cell line of malignant rhabdoid tumor

    Malignant rhabdoid tumor (MRT) is a sarcoma histologically characterized by rhabdoid cells and genetically characterized by loss of function of the...

    Taro Akiyama, Yuki Yoshimatsu, ... Tadashi Kondo in Human Cell
    Article 05 August 2022
  10. Establishment and characterization of NCC-MPNST6-C1: a novel patient-derived cell line of malignant peripheral nerve sheath tumors

    Malignant peripheral nerve sheath tumors (MPNSTs) are a rare subtype of mesenchymal tumors that arise from the sheath of peripheral nerves. MPNSTs...

    Yooksil Sin, Yuki Yoshimatsu, ... Tadashi Kondo in Human Cell
    Article 14 November 2021
  11. Chemotherapy and mismatch repair deficiency cooperate to fuel TP53 mutagenesis and ALL relapse

    Chemotherapy is a standard treatment for pediatric acute lymphoblastic leukemia (ALL), which sometimes relapses with chemoresistant features....

    Fan Yang, Samuel W. Brady, ... Bin-Bing S. Zhou in Nature Cancer
    Article 22 July 2021
  12. Exploring the nexus of nuclear receptors in hematological malignancies

    Hematological malignancies (HM) represent a subset of neoplasms affecting the blood, bone marrow, and lymphatic systems, categorized primarily into...

    Mukesh Kumar Manickasamy, Anjana Sajeev, ... Ajaikumar B. Kunnumakkara in Cellular and Molecular Life Sciences
    Article Open access 09 February 2024
  13. A rare KMT2A::CBL transcript in an acute monoblastic leukemia patient with an unfavorable outcome

    Background

    Lysine [K] methyltransferase 2A ( KMT2A , previously known as MLL ) gene rearrangements are common in acute leukemias of various lineages and...

    **glei Yu, Fengmei Song, ... Guoqing Wei in Molecular Biology Reports
    Article Open access 21 April 2024
  14. Cardiovascular Adverse Effects of Breast Cancer Chemotherapy

    Breast cancer is the most commonly diagnosed cancer globally, with more than 2.3 million cases per year and resulting in the death of 685,000 women...
    Haojun Huang, Liam R. Brunham in Biology of Women’s Heart Health
    Chapter 2023
  15. Catheter-associated blood stream infections due to Candida pararugosa in a patient with acute myeloid leukemia: A case report

    Infections caused by uncommon Candida species have dramatically increased in recent decades, mostly among hematological malignancies. This report...

    Elahe Nasri, Afsane Vaezi, ... Hamed Fakhim in Brazilian Journal of Microbiology
    Article 08 May 2023
  16. Epigenetic Modifiers and Their Inhibitors in Leukemia Treatment

    It seems quite unlikely that any adult cancer may arise as the result of single gene defect. Epigenetic alterations have been described in AML and...
    Rūta Navakauskienė, Dalius Navakauskas, ... Dalius Matuzevičius in Epigenetics and Proteomics of Leukemia
    Chapter 2021
  17. Network integration and modelling of dynamic drug responses at multi-omics levels

    Uncovering cellular responses from heterogeneous genomic data is crucial for molecular medicine in particular for drug safety. This can be realized...

    Nathalie Selevsek, Florian Caiment, ... Jos Kleinjans in Communications Biology
    Article Open access 15 October 2020
  18. NSP15

    Endoribonuclease NSP15Endoribonuclease NSP15 is vital for the replication and life cycle of the SARS-CoV-2 virus and is thus considered a compelling...
    Chapter 2023
  19. Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients

    While type I interferon (IFN) is best known for its key role against viral infection, accumulating preclinical and clinical data indicate that robust...

    Peter Holicek, Iva Truxova, ... Jitka Fucikova in Cell Death & Disease
    Article Open access 24 March 2023
  20. Recent advances in pluripotent stem cell-derived cardiac organoids and heart-on-chip applications for studying anti-cancer drug-induced cardiotoxicity

    Cardiovascular disease (CVD) caused by anti-cancer drug-induced cardiotoxicity is now the second leading cause of mortality among cancer survivors....

    Silin Liu, Chongkai Fang, ... Qingzhong **ao in Cell Biology and Toxicology
    Article 27 October 2023
Did you find what you were looking for? Share feedback.